-
公开(公告)号:JP5827625B2
公开(公告)日:2015-12-02
申请号:JP2012535564
申请日:2010-10-29
发明人: サンパリス,フォティーニ , ハーランド,ヘンリ
IPC分类号: A61K31/122 , A61K9/48 , A61K35/612 , A61P9/10 , A61P3/06 , A61P9/12 , A61P3/10 , A61P13/12 , A61P1/16 , A61P7/02 , A61P25/02 , A61P21/02 , A61P25/28 , A61P25/16 , A61P25/14 , A61K31/683
CPC分类号: A61K31/685 , A61K31/07 , A61K31/122 , A61K31/23 , A61K31/352 , A61K31/355 , A61K31/683 , A61K45/06 , C07F9/10 , Y10S514/824
-
公开(公告)号:JP2015147793A
公开(公告)日:2015-08-20
申请号:JP2015081001
申请日:2015-04-10
发明人: サンパリス,フォティーニ , ハーランド,ヘンリ
IPC分类号: A61K31/122 , A61K31/202 , A61P3/06 , A61P43/00 , A61K9/48 , A61K35/612 , A61K33/42
CPC分类号: A61K31/685 , A61K31/07 , A61K31/122 , A61K31/23 , A61K31/352 , A61K31/355 , A61K31/683 , A61K45/06 , C07F9/10 , Y10S514/824
摘要: 【課題】濃縮治療用リン脂質組成物の提供。 【解決手段】本発明は、式Iの化合物を含む濃縮治療用リン脂質組成物に関する。 【選択図】図1B
摘要翻译: 要解决的问题:提供浓缩的治疗性磷脂组合物。解决方案:本发明涉及包含式I化合物的浓缩治疗性磷脂组合物。
-
93.
公开(公告)号:JP5172281B2
公开(公告)日:2013-03-27
申请号:JP2007285980
申请日:2007-11-02
申请人: シャーブルック大学
发明人: ボドワン,アドリアン , マルタン,ジュヌヴィエーヴ
IPC分类号: A01K61/00 , C11B1/10 , A23D9/007 , A23D9/02 , A23K10/20 , A23K20/142 , A23K20/158 , A23L1/30 , A61K8/55 , A61K8/67 , A61K8/96 , A61K8/98 , A61K31/661 , A61K35/612 , A61P9/00 , A61P13/12 , A61P29/00 , A61Q19/00 , C11B1/00 , C11B1/02 , C11B5/00 , C11B11/00 , C11B13/00
CPC分类号: C11B1/10
-
公开(公告)号:JP4181305B2
公开(公告)日:2008-11-12
申请号:JP2000577261
申请日:1999-10-21
申请人: シャーブルック大学
发明人: アドリアン ボドワン, , ジュヌヴィエーヴ マルタン,
IPC分类号: A01K61/00 , C11B1/00 , A23D9/007 , A23D9/02 , A23K10/20 , A23K20/142 , A23K20/158 , A23L1/30 , A61K8/67 , A61K8/96 , A61K8/98 , A61K35/612 , A61P9/00 , A61P13/12 , A61Q19/00 , C11B1/10 , C11B5/00 , C11B11/00 , C11B13/00
CPC分类号: C11B1/10
-
95.
公开(公告)号:JP2008150586A
公开(公告)日:2008-07-03
申请号:JP2007285980
申请日:2007-11-02
申请人: Univ De Sherbrooke , シャーブルック大学
发明人: BEAUDOIN ADRIEN , MARTIN GENEVIEVE
IPC分类号: A01K61/00 , C11B1/10 , A23D9/007 , A23D9/02 , A23K10/20 , A23K20/142 , A23K20/158 , A23L1/30 , A61K8/55 , A61K8/67 , A61K8/96 , A61K8/98 , A61K31/661 , A61K35/612 , A61P9/00 , A61P13/12 , A61P29/00 , A61Q19/00 , C11B1/00 , C11B1/02 , C11B5/00 , C11B11/00 , C11B13/00
CPC分类号: C11B1/10
摘要: PROBLEM TO BE SOLVED: To provide a method for extracting a lipid fraction from a raw material derived from marine and aquatic animals. SOLUTION: This method comprises extracting a first liquid component and a first solid component of a phosphatide-containing lipid fraction from the raw material of the marine and aquatic animals by a ketone solvent, and then subjecting the solid component to solvent extraction using an alcohol or ethyl acetate (preferably ethyl acetate) to extract a residual soluble lipid fraction. The remaining non-soluble particulate component is also recovered since it is enriched in proteins and contains a useful amount of active enzymes. COPYRIGHT: (C)2008,JPO&INPIT
摘要翻译: 待解决的问题:提供从源自海洋和水生动物的原料中提取脂质部分的方法。 解决方案:该方法包括通过酮溶剂从海洋和水生动物的原料中提取含磷脂的脂质部分的第一液体组分和第一固体组分,然后使用 醇或乙酸乙酯(优选乙酸乙酯)以提取残留的可溶性脂质部分。 剩余的不溶性颗粒组分也被回收,因为它富含蛋白质并含有有用量的活性酶。 版权所有(C)2008,JPO&INPIT
-
公开(公告)号:JP2002527604A
公开(公告)日:2002-08-27
申请号:JP2000577261
申请日:1999-10-21
-
公开(公告)号:JP2002104975A
公开(公告)日:2002-04-10
申请号:JP2000298955
申请日:2000-09-29
申请人: SAKAI KAZUO , KOYO CHEMICAL KK
发明人: SAKAI KAZUO , TAKAMORI YOSHIMORI , SUGURO SHIORI
IPC分类号: A23L2/38 , A23L1/30 , A23L2/52 , A23L2/60 , A23L2/62 , A23L33/10 , A61K31/722 , A61K35/56 , A61K35/612 , A61P3/04 , C08B37/08
摘要: PROBLEM TO BE SOLVED: To obtain a medicine usable for amelioration and prophylaxis of obesity and highly excellent in safety, or a healthy food or the like or a food and drink having the excellent effects. SOLUTION: This anorectic agent is characterized by comprising a low- molecular chitosan or a derivative thereof having a weight-average molecular weight within the range of 80,000-110,000, preferably 90,000-100,000 and a number- average molecular weight within the range of 30,000-50,000, preferably 30,000-40,000 measured by GPC. The healthy food and drink contains the low- molecular chitosan or the derivative thereof.
-
98.
公开(公告)号:JP2001340435A
公开(公告)日:2001-12-11
申请号:JP2000160637
申请日:2000-05-30
申请人: HIDAKA AKEMICHI
发明人: KATAOKA NAGAAKI
IPC分类号: A01G31/00 , A23K10/12 , A23K10/22 , A23K10/26 , A23K10/30 , A23K20/00 , A23K20/163 , A23K20/20 , A61K35/02 , A61K35/60 , A61K35/612 , A61K35/618 , A61L9/01 , A61P3/02 , A61P9/00 , A61P43/00
摘要: PROBLEM TO BE SOLVED: To elute natural mineral components with a safe, cheap and simple operation from natural minerals, inorganic salts, inorganic oxides, shells, plants, or the like, and extract mineral components which are infinitely near natural organic minerals and absorbed well by living beings. SOLUTION: At least one or more than 2 minerals-containing substances such as natural minerals, inorganic salts, inorganic oxides, shells, plants, or the like, are added to a saccharide solution to obtain a natural mineral containing solution by eluting mineral components from the mineral containing substances into the saccharide solution by fermentation and decomposition action of the saccharide solution, and further, to obtain a purified natural mineral containing solution by aeration treatment and microorganism treatment followed by purification.
-
公开(公告)号:JPH0528208B2
公开(公告)日:1993-04-23
申请号:JP18987784
申请日:1984-09-11
申请人: KAO CORP
发明人: HARA KENJI , MANSEI KENJI
IPC分类号: A61K38/46 , A61K35/56 , A61K35/612 , A61K38/48 , A61P29/00
-
公开(公告)号:JPH0482840A
公开(公告)日:1992-03-16
申请号:JP19564490
申请日:1990-07-24
申请人: TAIYO FISHERY CO LTD
摘要: PURPOSE:To obtain an extremely excellent remedy for bacterial shock exhibiting strong antibacterial activity against Gram-negative bacteria and capable of neutralizing the bioactivity of lipid A by using a peptide extracted and separated from limulus as an active component. CONSTITUTION:The objective agent contains, as an active component, either one of peptides of formula I to formula V (the groups (1) and (2) and the groups (3)and (4) are directly bonded with each other; Arg-NH2 shows that carboxyl of arginine is amide form) and their pharmacologically allowable salts. The above peptide bonds to Gram-negative bacterial endotoxin to neutralize its biological effect and is useful as a remedy for Gram-negative bacterial blood disease and bacterial shock. It can be administered orally or parenterally at a rate of 0.1-1,000mg per one dose.
-
-
-
-
-
-
-
-
-